Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ORL.TO Stock Summary
In the News
ORL.TO Financial details
Company Rating
Sell
Market Cap
0
Income
101.72M
Revenue
8.42M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-34.13
Forward P/E
-
PEG
0.69
P/S
-
P/B
4.58
P/C
-
P/FCF
-
Quick Ratio
3.68
Current Ratio
4.33
Debt / Equity
0.5
LT Debt / Equity
0.45
-
-
EPS (TTM)
0.98
EPS next Y
-
EPS next Q
-
EPS this Y
8%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
37.57%
Revenue Q/Q
120.37%
EPS Q/Q
-17957.14%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-14%
ROC
-
Gross Margin
56%
Oper. Margin
6%
Profit Margin
-106%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.12-8.34
52W High
+3.5%
52W Low
+3.5%
RSI
-
Rel Volume
0.44
Avg Volume
43.91K
Volume
19.46K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.8218
-
-
Volatility
0%, 0%
Prev Close
0%
Price
8.28
Change
-
ORL.TO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-06-30
Metric | History | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.08 | 0.07 | 0.31 | 0.29 | 0.26 | |
Net income per share | 0.09 | 0.01 | 0.21 | -0.25 | -0.27 | |
Operating cash flow per share | -0.03 | -0.08 | -0.12 | -0.72 | -0.05 | |
Free cash flow per share | -0.05 | -0.12 | -0.34 | -1.45 | -0.34 | |
Cash per share | 0.29 | 1.36 | 1.07 | 0.65 | 0.78 | |
Book value per share | 1.03 | 2.16 | 2.41 | 2.28 | 2.02 | |
Tangible book value per share | 1.03 | 2.16 | 2.79 | 2.61 | 2.19 | |
Share holders equity per share | 1.03 | 2.16 | 2.41 | 2.28 | 2.02 | |
Interest debt per share | 0.01 | 0.01 | 0.71 | 1.02 | 1.08 | |
Market cap | 2.13B | 2.41B | 2.89B | 2.84B | 3.59B | |
Enterprise value | 2.08B | 2.09B | 2.8B | 2.92B | 3.67B | |
P/E ratio | 109.66 | 1.25K | 53.03 | -42.32 | -40.14 | |
Price to sales ratio | 123.93 | 138.49 | 35.67 | 36.88 | 42.38 | |
POCF ratio | -332.38 | -136.31 | -95.3 | -14.84 | -228.79 | |
PFCF ratio | -185.94 | -84.07 | -32.29 | -7.43 | -31.7 | |
P/B Ratio | 9.78 | 4.79 | 4.58 | 4.72 | 5.39 | |
PTB ratio | 9.78 | 4.79 | 4.58 | 4.72 | 5.39 | |
EV to sales | 120.99 | 120.31 | 34.44 | 37.91 | 43.3 | |
Enterprise value over EBITDA | 86.32 | 408.38 | 37.59 | -74.38 | 207.65 | |
EV to operating cash flow | -324.48 | -118.41 | -92.01 | -15.26 | -233.78 | |
EV to free cash flow | -181.52 | -73.04 | -31.18 | -7.64 | -32.39 | |
Earnings yield | 0.01 | 0 | 0.02 | -0.02 | -0.02 | |
Free cash flow yield | -0.01 | -0.01 | -0.03 | -0.13 | -0.03 | |
Debt to equity | 0 | 0 | 0.29 | 0.42 | 0.5 | |
Debt to assets | 0 | 0 | 0.16 | 0.22 | 0.25 | |
Net debt to EBITDA | -2.1 | -61.71 | -1.34 | -2.02 | 4.43 | |
Current ratio | 8.7 | 42.57 | 3.27 | 2.15 | 4.33 | |
Interest coverage | -5.67 | -18.24 | 0.72 | -0.82 | 0.26 | |
Income quality | -0.33 | -9.2 | -0.56 | 2.85 | 0.18 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.43 | 0.57 | 0.14 | 0.16 | 0.16 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.79 | 0.62 | 1.95 | 1 | 6.22 | |
Capex to revenue | -0.29 | -0.63 | -0.73 | -2.48 | -1.15 | |
Capex to depreciation | -2.89 | -4.55 | -5.45 | -9.45 | -5.2 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.46 | 0.63 | 3.36 | 3.6 | 3.5 | |
ROIC | -0.04 | 0.23 | 0.01 | -0.01 | 0.02 | |
Return on tangible assets | 0.08 | 0 | 0.05 | -0.06 | -0.07 | |
Graham Net | 0.29 | 1.46 | -0.22 | -0.97 | -0.98 | |
Working capital | 81.63M | 366.82M | 251.95M | 121.28M | 254.8M | |
Tangible asset value | 218.02M | 502.1M | 733.78M | 689.68M | 724.36M | |
Net current asset value | 70.1M | 354.93M | -15.47M | -228.19M | -292.29M | |
Invested capital | 0 | 0 | 0.29 | 0.42 | 0.5 | |
Average receivables | 16.02M | 38.39M | 37.48M | 19.46M | 19.94M | |
Average payables | 9.71M | 8.38M | 16.74M | 27.62M | 27.83M | |
Average inventory | 6.46M | 6.47M | 26.06M | 37.98M | 37.76M | |
Days sales outstanding | 516.4 | 1.1K | 101.25 | 77.67 | 101.09 | |
Days payables outstanding | 214.01 | 191.62 | 216.78 | 198.57 | 257.34 | |
Days of inventory on hand | 147.99 | 167.18 | 380.17 | 206.09 | 439.74 | |
Receivables turnover | 0.71 | 0.33 | 3.61 | 4.7 | 3.61 | |
Payables turnover | 1.71 | 1.9 | 1.68 | 1.84 | 1.42 | |
Inventory turnover | 2.47 | 2.18 | 0.96 | 1.77 | 0.83 | |
ROE | 0.09 | 0 | 0.09 | -0.11 | -0.13 | |
Capex per share | -0.02 | -0.05 | -0.23 | -0.72 | -0.3 |
Quarterly Fundamentals Overview
Last date of statement is 2021-06-30 for Q4
Metric | History | 2018-06-30 | 2018-12-31 | 2019-06-30 | 2020-06-30 | 2021-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -315.95M | -283.82M | -99.72M | 79.48M | 78.33M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0.29 | 0.42 | 0.5 | |
Debt to assets | 0 | 0 | 0.16 | 0.22 | 0.25 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 42.57 | 58.66 | 3.27 | 2.15 | 4.33 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 366.82M | 343.96M | 251.95M | 121.28M | 254.8M | |
Tangible asset value | 502.1M | 527.81M | 733.78M | 689.68M | 724.36M | |
Net current asset value | 354.93M | 331.39M | -15.47M | -228.19M | -292.29M | |
Invested capital | 0 | 0 | 0.29 | 0.42 | 0.5 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ORL.TO Frequently Asked Questions
What is Allkem Limited stock symbol ?
Allkem Limited is a AU stock , located in Brisbane of Queensland and trading under the symbol ORL.TO
What is Allkem Limited stock quote today ?
Allkem Limited stock price is $8.28 today.
Is Allkem Limited stock public?
Yes, Allkem Limited is a publicly traded company.